re: ANX's Presentation at the Bio CEO & Investors Conference:

After watching ANX's presentation a couple of times yesterday, these are my impressions.

First, CEO Culley said that they should hear from the FDA about their decision to accept or deny the NDA for ANX-530 "in the next two weeks or so". This is something we all knew already, because the NDA was submitted in the final days of December 2009. The FDA has 60 days to make it's decision to accept, ask for more data (which means a long delay), or outright reject the NDA.

That gives the FDA until the last week of February or the first week of March to give ANX their decision on the NDA. I've been following small cap and micro cap biotech companies for about two years, and in all that time I've never seen the FDA render a decision early. So the best we can hope for is for the company to get their decision around the first of March, and to release a Press Release soon thereafter.

Yesterday's presentation was nearly a carbon copy of the presentation they made at the OneMedForum conference in San Francisco on December 15th 2009. The slide show was exactly the same, and the CEO's speech was almost identical. There were no new developments mentioned that we weren't already aware of. It was a very good presentation though, and I really like Mr. Culley's enthusiasm and speaking style.

The purpose of these types of conferences is to inform investors of what the company is all about, and to hopefully get them to invest in the company. I hope that Mr. Culley was successful in doing just that.

If you would like to listen to the presentation, here is a link to go to the webcast:

http://ir.adventrx.com/phoenix.zhtml?c=75414&p=irol-IRHome

Here is a post I made last night on the ANX Board at the InvestorsHub.com (IHUB) site:

http://investorshub.advfn.com/boards/read_msg.aspx?message_id=46474923

It is an analysis of ANX's daily chart using a number of Technical Indicators.

Happy Trading!,
zigzagman